Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
about
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.Epstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients.Hodgkin lymphoma: an update on its biology with new insights into classification.EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis.Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era.Epstein Barr virus latent membrane protein-1 in Hodgkin's lymphoma in Nigerians.Prognostic factors in hodgkin lymphomaDisparities in survival after Hodgkin lymphoma: a population-based studyEpstein-Barr virus infection and clinical outcome in breast cancer patients correlate with immune cell TNF-α/IFN-γ responseClinical, molecular, and environmental risk factors for hodgkin lymphoma.Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.Incidence patterns and outcomes for hodgkin lymphoma patients in the United StatesEBV in Hodgkin Lymphoma.Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma.Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.LMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.Brazilian experience using high dose sequential chemotherapy followed by autologous hematopoietic stem cell transplantation for malignant lymphomas.The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma.Targeting tumours by adoptive transfer of immune cells.Outcome of a risk-related therapeutic strategy used prospectively in a population-based study of Hodgkin's lymphoma in adolescents.Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma.Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Immunotherapies for Hodgkin's lymphoma.Laboratory assays for Epstein-Barr virus-related disease.Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.Improvements in survival after follicular lymphoma by race/ethnicity and socioeconomic status: a population-based studySickle cell trait is not associated with endemic Burkitt lymphoma: an ethnicity and malaria endemicity-matched case-control study suggests factors controlling EBV may serve as a predictive biomarker for this pediatric cancerEpstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.Bfl-1 is a crucial pro-survival nuclear factor-κB target gene in Hodgkin/Reed-Sternberg cells.Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.Epstein-Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma.Monoamine oxidase A is highly expressed in classical Hodgkin lymphoma.Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus.
P2860
Q33373091-CD4CA3F1-A2BB-4F97-AFA2-DBF8280946BBQ33409443-C3AF73B8-CEF4-448D-9018-415F5986D5FCQ33439883-B90326C5-D6DC-4385-8C6A-26E2D1D19AD2Q33588862-B03F43A8-E2BF-4F2B-B6D4-688009CAA7F7Q33711558-0433DF39-9A3D-497C-A61A-419684A6231AQ33718809-D1B26599-32D0-45CE-8DF1-96C6F6286EFEQ33918638-825B389E-6313-485E-B0CE-4966BBBF0C10Q33920147-A1AA5486-81CE-4A79-AEF3-8DC8E5F80CC3Q33925220-88A9A65C-D975-45A9-A9F7-58B1E6C925ADQ34227303-F98A62F1-2038-4FBB-886C-42FFE6673D33Q34362539-84FF2A0E-A9A0-4EF5-A03E-4F3804108B15Q34430587-1FFD01DA-C386-4814-8D40-DB9BDCBC9B28Q34442533-23798088-F1EC-4CCC-9498-82C410CF4542Q34549468-CA517146-1759-46AF-AE33-E8B4AE8CCFF9Q35005158-59EBE768-C3CD-49D6-ADF4-315BB1BE1990Q35258785-F2E84B37-B5A5-42EF-9CF1-A7C7B87F3AB4Q35539719-0E03C733-7EA1-4B97-897A-1609099B1624Q36283067-719F43E4-4286-4155-A5DA-4CDED0292366Q36327447-537E1B24-7A81-4AA6-BF21-24A90C8FCCB7Q36478870-744F06FC-C2FB-4936-A628-188E78D0BFBEQ36608682-D3294720-8C5D-435A-AD19-2628CFE1B23EQ36615084-BB73E966-D66A-400F-B969-7953611EC61BQ36619445-2B19CB82-DA26-4A69-81F9-74747BCFA77CQ37004635-B59ECC45-D682-4845-9B22-516415947A2DQ37006427-6AEB9B23-46F7-4C01-B07A-7987EDBA1CA0Q37192117-5A772707-EEFB-4FB3-A1AD-57F2B0D53AE0Q37223616-5A52EA89-DE64-42C5-BFC6-015DDA2D8F07Q37242294-9A3405EE-2596-427B-9A94-D050F4A5E9E0Q37316016-80FC7EA4-B875-427E-809E-CFB521947027Q37426438-5EE61672-247A-4911-A4B5-FBFBE671EFEAQ37529430-551E5720-C131-474A-8AB2-E9E13DDCC4F6Q37532169-EC9BB35C-F03C-4DFA-994F-5033678628ABQ38775871-A0941139-D53D-4475-92D8-BABB80DC7858Q39558930-F6EA013F-B3FB-4503-8690-96EDDDAEEA35Q39992915-9E1439AD-4DBF-4E12-892B-0D5F410752FAQ40108143-D9249A0D-0293-4429-B84D-7465B2B940F5Q40117250-9178968C-C765-44B0-88E1-2404AB7DF6FCQ40538712-9E530F27-55F7-42CC-B5B9-5EE704D0C24BQ40990232-43AD719C-1260-49E5-9A8B-77F8460A46C7Q41727799-DB011141-6426-4989-B170-AA958D17D37B
P2860
Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Epstein-Barr virus as a marker ...... oma: a population-based study.
@ast
Epstein-Barr virus as a marker ...... oma: a population-based study.
@en
type
label
Epstein-Barr virus as a marker ...... oma: a population-based study.
@ast
Epstein-Barr virus as a marker ...... oma: a population-based study.
@en
prefLabel
Epstein-Barr virus as a marker ...... oma: a population-based study.
@ast
Epstein-Barr virus as a marker ...... oma: a population-based study.
@en
P2093
P50
P356
P1476
Epstein-Barr virus as a marker ...... oma: a population-based study.
@en
P2093
Fiona E Craig
Joseph A Digiuseppe
Margaret L Gulley
Richard F Ambinder
Risa B Mann
Ronald F Dorfman
P304
P356
10.1200/JCO.2005.02.6310
P407
P577
2005-09-26T00:00:00Z